Alexion Pharmaceuticals Inc Asset Turnover Ratio (ALXN), as of first quarter 2021, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Alexion Pharmaceuticals Inc   (NASDAQ: ALXN)
 

Alexion Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Alexion Pharmaceuticals Inc asset turnover ratio, the ability of Alexion Pharmaceuticals Inc 's assets to generate revenue in the first quarter 2021, increased sequentially to 0.36 in the first quarter (Mar 31 2021), yet the ratio remained below the average, as ALXN's position remain challenging.

Within sector 146 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2021 compared to the preceding quarter from 2966 to 2980.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ALXN Asset Turnover Ratio (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter
Y / Y Asset Change 1.58 % 3.11 % 16.98 % 13.24 % 29.64 %
Y / Y Revenue Change 13.27 % 14.99 % 25.78 % 20.05 % 26.69 %
Asset Turnover Ratio (TTM) 0.36 0.35 0.34 0.33 0.33
ALXN's Total Ranking # 2980 # 2966 # 2862 # 2315 # 2860
Seq. Asset Change 3.1 % 3.18 % 5.06 % -9.1 % 4.65 %
Seq. Revenue Change 2.81 % 0.2 % 9.98 % -0.01 % 4.37 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 147
Healthcare Sector # 427
Overall Market # 2980

Asset Turnover Ratio Statistics
High Average Low
19.54 5.52 4.15
(Sep. 30, 2015)   (Sep. 30, 2013)




ALXN Company Profile • Back to ALXN Efficiency Comparisons • Compare ALXN Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2021, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2021 Assets at quarter ending Mar 31 2021
Healthlynked Corp  0.93 $ 6.581  Millions$ 7.114  Millions
Siga Technologies Inc  0.92 $ 127.153  Millions$ 137.609  Millions
Elite Pharmaceuticals Inc   0.92 $ 25.381  Millions$ 27.571  Millions
Rigel Pharmaceuticals Inc  0.91 $ 133.878  Millions$ 146.866  Millions
Universal Health Services Inc   0.91 $ 11,742.217  Millions$ 12,924.366  Millions
Neurometrix Inc   0.90 $ 7.361  Millions$ 8.165  Millions
Invacare Holdings Corporation  0.89 $ 828.451  Millions$ 928.073  Millions
Ufp Technologies Inc   0.89 $ 179.695  Millions$ 202.567  Millions
West Pharmaceutical Services Inc   0.89 $ 2,326.100  Millions$ 2,627.150  Millions
Resmed Inc   0.88 $ 4,029.320  Millions$ 4,591.700  Millions
Antares Pharma Inc   0.87 $ 158.603  Millions$ 182.422  Millions
Rockwell Medical inc   0.85 $ 61.813  Millions$ 72.754  Millions
Sunwin Stevia International Inc.  0.85 $ 25.379  Millions$ 29.902  Millions
Regen Biopharma Inc   0.85 $ 0.110  Millions$ 0.130  Millions
Lhc Group Inc   0.85 $ 2,075.168  Millions$ 2,454.911  Millions
Biodesix Inc   0.85 $ 69.327  Millions$ 82.034  Millions
Pra Health Sciences Inc   0.83 $ 3,333.432  Millions$ 4,005.815  Millions
Star Equity Holdings Inc   0.83 $ 71.660  Millions$ 86.230  Millions
Luna Innovations Inc  0.82 $ 91.839  Millions$ 111.753  Millions
The Pennant Group Inc   0.82 $ 404.767  Millions$ 493.914  Millions
Skinvisible Inc   0.81 $ 0.156  Millions$ 0.192  Millions
Aquestive Therapeutics Inc   0.81 $ 48.206  Millions$ 59.694  Millions
Ppd Inc   0.81 $ 4,987.392  Millions$ 6,177.473  Millions
Psychemedics Corporation  0.80 $ 19.536  Millions$ 24.535  Millions
Labcorp Holdings Inc   0.79 $ 15,316.200  Millions$ 19,269.375  Millions
Cerus Corporation  0.79 $ 171.773  Millions$ 217.711  Millions
Accuray Incorporated  0.79 $ 380.330  Millions$ 483.347  Millions
Incyte Corporation  0.79 $ 2,702.913  Millions$ 3,435.526  Millions
Tandem Diabetes Care Inc   0.79 $ 541.941  Millions$ 689.979  Millions
Meridian Bioscience Inc   0.78 $ 327.131  Millions$ 422.037  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.